"It was important for me to shed light on that world as well," he says. "There's so much, so much heartbreak for the people who do this kind of work." He adds: "You spend years making incremental progress, potentially, hopefully, then often it's a dead end"
In the race for a COVID vaccine, how did a couple of companies who had never produced a successful vaccine make it to the finish line so quickly? Gregory Zuckerman talks about his book, A Shot to Save the World, with EconTalk's Russ Roberts about the daring, deranged, and damaged visionaries behind one of science and medicine's great success stories.